Novel Mechanism for Plasma Glucose–Lowering Action of Metformin in Streptozotocin-Induced Diabetic Rats
- 1Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan, R.O.C
- 2Department of Pharmacy, Tajen University, Yen-Pou, Ping Tung Shien, Taiwan, R.O.C
- 3Department of Internal Medicine, Pao Chien Hospital, Ping Tung City, Taiwan, R.O.C
- 4Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan, R.O.C
- Address correspondence and reprint requests to Prof. Juei-Tang Cheng, PhD, FCP, Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan 70101, R.O.C. E-mail: jtcheng{at}mail.ncku.edu.tw
Abstract
To better understand the insulin-independent plasma glucose–lowering action of metformin, we used streptozotocin (STZ)-induced diabetic rats to investigate the possible mechanisms. Oral intake of metformin decreased the plasma glucose of STZ-induced diabetic rats with a parallel increase of plasma β-endorphin–like immunoreactivity (BER). Mediation of opioid μ-receptors in the action of metformin was identified by the blockade of receptors with antagonist in STZ-induced diabetic rats and the failure of action in opioid μ-receptor knockout diabetic mice. Release of BER from adrenal glands by metformin was characterized, using bilateral adrenalectomy and the release of BER from isolated adrenal medulla of STZ-induced diabetic rats. Repeated treatment with metformin in STZ-induced diabetic rats increased the mRNA and protein levels of GLUT-4 in soleus muscle that was blocked by naloxonazine. Reduction of the mRNA or protein levels of hepatic PEPCK was also impeded in the same group of STZ-induced diabetic rats. In conclusion, our results provide novel mechanisms for the plasma glucose–lowering action of metformin, via an increase of β-endorphin secretion from adrenal glands to stimulate opioid μ-receptor linkage, leading to an increase of GLUT-4 gene expression and an attenuation of hepatic PEPCK gene expression in STZ-induced diabetic rats.
- AMPK, 5′AMP-activated protein kinase
- BER, β-endorphin–like immunoreactivity
- PKC, protein kinase C
- STZ, streptozotocin
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted November 28, 2005.
- Received July 22, 2005.
- DIABETES
